ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 2429

$1.51M Total Retail Price of All Prescriptions

Rank: 12 out of 2429

661 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 661 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 661 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 21,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 1,669 1,293 1 2
FUROSEMIDE 1,023 806 2 5
AMLODIPINE BESYLATE 826 738 3 4
HYDROCHLOROTHIAZIDE 809 751 4 10
SIMVASTATIN 787 612 5 1
HYDROCODONE-ACETAMINOPHEN 764 472 S3 6 6
LEVOTHYROXINE SODIUM 761 582 7 3
OMEPRAZOLE 733 490 8 7
WARFARIN SODIUM 633 517 9 11
PRAVASTATIN SODIUM 607 503 10 16
SERTRALINE HCL 601 467 11 23
METOPROLOL TARTRATE 579 453 12 9
POTASSIUM CHLORIDE 503 406 13 14
ATENOLOL 495 411 14 15
METFORMIN HCL 462 329 15 8
TRAMADOL HCL 443 348 16 17
TRAZODONE HCL 426 228 17 50
LOSARTAN POTASSIUM 414 382 18 22
METOPROLOL SUCCINATE 406 334 19 12
NAMENDA 397 375 20 35
GABAPENTIN 358 211 21 18
DONEPEZIL HCL 336 324 22 26
CITALOPRAM HBR 316 255 23 19
RANITIDINE HCL 279 173 24 24
ALENDRONATE SODIUM 246 213 25 20
GLIPIZIDE ER 231 165 26 72
CLOPIDOGREL 220 168 27 31
RISPERIDONE 219 119 28 52
TAMSULOSIN HCL 216 203 29 29
QUETIAPINE FUMARATE 214 150 30 77
OLANZAPINE 213 125 31 101
FLUTICASONE PROPIONATE 212 159 32 39
ALLOPURINOL 197 171 33 33
LOVASTATIN 191 172 34 30
LANTUS 191 91 34 45
PANTOPRAZOLE SODIUM 191 170 34 34
FENTANYL 187 146 S2 37 59
DIVALPROEX SODIUM ER 181 66 38 111
SPIRIVA 175 114 39 54
CARVEDILOL 175 147 39 21
METFORMIN HCL ER 167 153 41 65
CARBIDOPA-LEVODOPA 164 136 42 88
NEXIUM 157 116 43 37
PROAIR HFA 152 87 44 41
FAMOTIDINE 151 124 45 42
ADVAIR DISKUS 149 89 46 49
TRIAMCINOLONE ACETONIDE 148 95 47 99
GLIPIZIDE XL 142 134 48 117
NAPROXEN 140 84 49 75
GLIPIZIDE 136 101 50 47
PLAVIX 134 113 51 44
FLUOXETINE HCL 133 69 52 61
ZOLPIDEM TARTRATE 129 104 53 28
MIRTAZAPINE 128 90 54 63
LAMOTRIGINE 127 40 55 130
SULFAMETHOXAZOLE-TRIMETHOPRIM 126 94 56 102
PREDNISONE 123 109 57 38
ATORVASTATIN CALCIUM 122 92 58 13
VENLAFAXINE HCL ER 120 70 59 98
ALBUTEROL SULFATE 119 82 60 129
PHENYTOIN SODIUM EXTENDED 117 63 61 108
JANUVIA 110 91 62 66
POLYETHYLENE GLYCOL 3350 110 82 62 56
EVISTA 108 108 64 185
SEROQUEL 108 83 64 169
PAROXETINE HCL 107 92 66 67
AZITHROMYCIN 107 90 66 46
ABILIFY 103 33 68 121
FINASTERIDE 99 99 69 126
CYCLOBENZAPRINE HCL 94 49 R 70 69
HALOPERIDOL 92 32 71 146
OXYCODONE HCL 90 35 S2 72 226
CLONIDINE HCL 88 45 73 68
CARBAMAZEPINE 88 58 73 133
DIGOXIN 88 88 73 43
SPIRONOLACTONE 86 63 76 62
DIPHENOXYLATE-ATROPINE 84 59 77 348
ESCITALOPRAM OXALATE 83 40 78 74
PROPRANOLOL HCL 83 70 78 119
BUPROPION HCL 82 33 80 323
KLOR-CON 10 81 81 81 89
OXYCONTIN 80 40 S2 82 212
DIVALPROEX SODIUM 80 62 82 78
OXYBUTYNIN CHLORIDE 80 55 82 122
CRESTOR 79 53 85 25
OXYBUTYNIN CHLORIDE ER 77 36 86 79
BENZTROPINE MESYLATE 75 20 R 87 110
CLOZAPINE 74 0 88 147
ISOSORBIDE MONONITRATE ER 74 67 88 55
ACTOS 74 60 88 114
BUPROPION HCL SR 71 53 91 204
CELEBREX 70 70 92 97
LANTUS SOLOSTAR 70 58 92 100
LACTULOSE 70 0 92 142
LITHIUM CARBONATE 69 33 95 218
DIOVAN 69 69 95 36
VENLAFAXINE HCL 67 34 97 279
GEMFIBROZIL 66 47 98 107
ZIPRASIDONE HCL 65 0 99 274
BUSPIRONE HCL 65 36 99 160
TRICOR 61 49 101 125
THEOPHYLLINE ANHYDROUS 60 60 102 215
CEPHALEXIN 59 37 103 104
AMOX TR-POTASSIUM CLAVULANATE 58 41 104 159
ROPINIROLE HCL 57 50 105 92
SUCRALFATE 56 13 106 150
NITROGLYCERIN PATCH 55 37 107 155
LYRICA 55 43 107 95
PROMETHAZINE HCL 53 21 R 109 156
LANSOPRAZOLE 52 39 110 163
EXELON 51 30 111 132
BUPROPION XL 51 12 111 294
ACTONEL 50 50 113 188
KLOR-CON M20 50 39 113 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.